Cargando…

De-escalating chemotherapy for stage I–II gastric neuroendocrine carcinoma? A real-world competing risk analysis

BACKGROUND: The role of adjuvant chemotherapy in gastric neuroendocrine neoplasms (GNEC) has not been well clarified yet. The study was designed to investigate the potential effect of adjuvant chemotherapy in stage I–II GNEC patients and construct a predictive nomogram. METHOD: Stage I–II GNEC patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Du, Danwei, Xie, Yangyang, Li, Xiaowen, Ni, Zhongkai, Shi, Jinbo, Huang, Hai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163728/ https://www.ncbi.nlm.nih.gov/pubmed/37149679 http://dx.doi.org/10.1186/s12957-023-03029-2

Ejemplares similares

The role of chemotherapy in patients with stage IB gastric adenocarcinoma: a real-world competing risk analysis
por: Xie, Yangyang, et al.
Publicado: (2022)

A novel nomogram for identifying candidates for adjuvant chemotherapy in patients with stage IB gastric adenocarcinoma
por: Xie, Yangyang, et al.
Publicado: (2023)

De-escalating chemotherapy for stage II colon cancer?
por: Fu, Jianfei, et al.
Publicado: (2019)

Identification of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in alimentary tract malignancies
por: Xie, Yangyang, et al.
Publicado: (2023)

Anatomic Subsites and Prognosis of Gastric Signet Ring Cell Carcinoma: A SEER Population-Based 1 : 1 Propensity-Matched Study
por: Xie, Yangyang, et al.
Publicado: (2022)

Real de-escalation or escalation in disguise?
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2023)

Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer
por: Batra, Atul, et al.
Publicado: (2020)

The role of adjuvant chemotherapy for patients with stage II and stage III gastric adenocarcinoma after surgery plus D2 lymph node dissection: a real-world observation
por: Chiu, Chang-Fang, et al.
Publicado: (2016)

Enhanced Efficacy of Chemotherapy by Addition of Immune Checkpoint Inhibitors in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung: A Real-World Analysis
por: Meng, Lingbin, et al.
Publicado: (2023)

Real world use of lanreotide in neuroendocrine tumors
por: Siddiqui, Zeba, et al.
Publicado: (2023)

Dose-Escalated Robotic SBRT for Stage I–II Prostate Cancer
por: Meier, Robert
Publicado: (2015)

P015: Real World Escalated BEACOPDac Delivers Similar Outcomes to Escalated BEACOPP While Potentially Reducing Haematopoietic and Reproductive Toxicity
por: Santarsieri, Anna, et al.
Publicado: (2022)

Postoperative chemoradiotherapy in gastric cancer – a phase I/II dose-finding study of radiotherapy with dose escalation of cisplatin and capecitabine chemotherapy
por: Jansen, E P M, et al.
Publicado: (2007)

Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis
por: Singh, Harpreet, et al.
Publicado: (2023)

Frequency and Clinical Outcomes of CYP2C19 Genotype-Guided Escalation and De-escalation of Antiplatelet Therapy in a Real-World Clinical Setting
por: Martin, Jesse, et al.
Publicado: (2019)

Chemotherapy for the initial treatment of metastatic prostate adenocarcinoma and neuroendocrine carcinoma at diagnosis: real world application and impact in the SEER database (2004 –2018)
por: Wang, Shihua, et al.
Publicado: (2023)

Novel staging for gastric neuroendocrine neoplasms by incorporating the WHO grading into the TNM staging system
por: Zhang, Rihong, et al.
Publicado: (2022)

A prospective study of surgery and adjuvant chemotherapy for primary gastric lymphoma stage II.
por: Takenaka, T., et al.
Publicado: (1997)

Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
por: Guo, Jianping, et al.
Publicado: (2023)

Chemotherapy in Neuroendocrine Tumors
por: Das, Satya, et al.
Publicado: (2021)

Threatened Reef Corals of the World
por: Huang, Danwei
Publicado: (2012)

A real-world evidence of efficacy of palliative gastrectomy plus chemotherapy in metastatic gastric cancer patients
por: Yang, Lu-Ping, et al.
Publicado: (2019)

Patient perspectives on chemotherapy de‐escalation in breast cancer
por: Rocque, Gabrielle B., et al.
Publicado: (2021)

Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
por: Yao, James C, et al.
Publicado: (2017)

Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
por: Patel, Dipen, et al.
Publicado: (2022)

Adjuvant chemotherapy, extent of resection, and immunoistochemical neuroendocrine markers as prognostic factors of early‐stage large‐cell neuroendocrine carcinoma
por: Andreetti, Claudio, et al.
Publicado: (2022)

The Changing Role of Gene-Expression Profiling in the Era of De-escalating Adjuvant Chemotherapy in Early-Stage Breast Cancer
por: van Steenhoven, J. E. C., et al.
Publicado: (2019)

Adverse Prognostic Impact of Postoperative Complications After Gastrectomy for Patients With Stage II/III Gastric Cancer: Analysis of Prospectively Collected Real-World Data
por: Song, Jeong Ho, et al.
Publicado: (2021)

Gastric Neuroendocrine Tumor
por: Kargwal, Naresh, et al.
Publicado: (2021)

Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma
por: Mishima, Saori, et al.
Publicado: (2018)

Optimal postoperative surveillance strategies for cancer survivors with gastric neuroendocrine carcinoma based on individual risk: a multicenter real-world cohort study
por: Xu, Bin-bin, et al.
Publicado: (2023)

Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer
por: Chau, Ian, et al.
Publicado: (2019)

Chemotherapy for Metastatic Gastric Cancer: Does Age Matter? A Single-Center, Retrospective, Real-World Study
por: Liao, Po-Wei, et al.
Publicado: (2022)

Ten-Year Outcomes Of Intensity-Modulated Radiotherapy (IMRT) Combine With Chemotherapy Versus IMRT Alone For Stage II Nasopharyngeal Carcinoma In The Real-World Study (RWD)
por: Ding, Xing-Chen, et al.
Publicado: (2019)

INFECTIOUS DISEASE: Americas’ Dengue Escalation Is Real—and Shifting
por: Weinhold, Bob
Publicado: (2010)

Are segments of the developing world competing in end-stage renal disease (ESRD)?
por: Mungrue, Kameel
Publicado: (2008)

Neoadjuvant PD-1 blockade plus chemotherapy versus chemotherapy alone in locally advanced stage II-III gastric cancer: A single-centre retrospective study
por: Zhang, Xuchen, et al.
Publicado: (2023)

Real-world treatment patterns of gastrointestinal neuroendocrine tumors: A claims database analysis
por: Benson III, Al B, et al.
Publicado: (2017)

Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy
por: Hentzen, Stijn, et al.
Publicado: (2023)

Neuroendocrine and neuroimmune adaptation to Chronic Escalating Distress (CED): A novel model of chronic stress
por: Lovelock, Dennis F., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mndcjo01ujblnr6ajfvrc4i68f